We develop highly efficient biopharmaceuticals in plants

We at Greenovation develop next generation therapeutics using our proprietary BryoTechnology platform.

Our core competency is optimization and effective production of highly-efficient glycoproteins for the treatment of orphan diseases.

GMP compliant manufacturing of our products is performed in Greenovation’s state-of-the-art wave-bag bioreactor system.

Greenovation is a privately owned biopharmaceutical company based in Heilbronn, Germany, that was founded in 1999 by Prof. Dr. Ralf Reski and Prof. Dr. Gunther Neuhaus. Today, Zukunftsfonds Heilbronn and
L-Bank (Karlsruhe) are main owners of the Greenovation Biotech GmbH.